Photodynamic therapy for localized infections-State of the art

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 3-4, 2009, Pages 170-188

  Dai, Tianhong ^a,b   Huang, Ying Ying ^a,b,c   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Bacteria; Burn; Fungus; Localized infection; Photodynamic therapy; Photosensitizer; Skin; Virus; Wound

Indexed keywords

3 BIS(N,N DIBUTYLAMINO)PHENOTHIAZINIUM BROMIDE; 5 PHENYL 10,15,20 TRIS(N METHYL 4 PYRIDYL)PORPHYRIN CHLORIDE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BENZO(A)PHENOSELENAZINIUM CHLORIDE; BENZO(A)PHENOTHIAZINIUM CHLORIDE; BLC 1010; CHLORINE DERIVATIVE; GLUTATHIONE; HEMATOPORPHYRIN DERIVATIVE; HYPOCHLORITE; METHYLENE BLUE; PAROMOMYCIN; PHOTOFRIN II; PHOTOGEM; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; POLYHEMATOPORPHYRIN ESTER; POLYHEMATOPORPHYRIN ETHER; POLYLYSINE CHLORINE E6 CONJUGATE; PORPHYRIN; PP 904; PPA 904; PROTOPORPHYRIN; TOLONIUM CHLORIDE; TROLOX C; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERTEPORFIN; XF 73;

ACNE; ACNE VULGARIS; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BIOLUMINESCENCE; BLOODSTREAM INFECTION; BLUE LIGHT; BURN; BURN INFECTION; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DISEASE MODEL; DISINFECTION; DRUG EFFICACY; DRUG MONITORING; ENDODONTICS; ERYTHRASMA; EX VIVO STUDY; EXPERIMENTAL MODEL; FUSOBACTERIUM INFECTION; GASTROINTESTINAL INFECTION; GENITAL HERPES; HAEMOPHILUS INFECTION; HERPES SIMPLEX; HUMAN; IN VIVO STUDY; INFECTION; INFECTION RISK; LARYNX PAPILLOMATOSIS; LEG ULCER; LEISHMANIASIS; LIGHT EXPOSURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLLUSCUM CONTAGIOSUM; MOUTH INFECTION; MYCOBACTERIOSIS; NEUTROPENIA; NONHUMAN; OSTEOMYELITIS; OTITIS MEDIA; PAPILLOMATOSIS; PERIODONTAL DISEASE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RED LIGHT; REVIEW; ROSACEA; SCAR FORMATION; SIDE EFFECT; SKIN INFECTION; SKIN LEISHMANIASIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; THRUSH; TOOTH INFECTION; TUBERCULOSIS; VERRUCA VULGARIS; VIBRIOSIS; VIRUS INFECTION; WHITE LIGHT; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; HUMANS; INFECTION; MODELS, BIOLOGICAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; FUNGI;

EID: 70449658674     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.10.008     Document Type: Review

References (152)

1. Bell S.G. Antibiotic resistance: is the end of an era near?. Neonatal Netw 22 (2003) 47-54
2. Poole M.D. Are we facing the end of the antibiotic era?. Ear Nose Throat J 72 (1993) 433
3. Harrison J.W., and Svec T.A. The beginning of the end of the antibiotic era? Part II. Proposed solutions to antibiotic abuse. Quintessence Int 29 (1998) 223-229
4. Mroz P., and Hamblin M.R. Advances in photodynamic therapy: basic, translational and clinical (2008), Artech House, Norwood, MA
5. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 39 (1997) 1-18
6. O'Riordan K., Sharlin D.S., Gross J., et al. Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother 50 (2006) 1828-1834
7. Wilson M. Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochem Photobiol Sci 3 (2004) 412-418
8. Bergmans L., Moisiadis P., Huybrechts B., Van Meerbeek B., Quirynen M., and Lambrechts P. Effect of photo-activated disinfection on endodontic pathogens ex vivo. Int Endod J 41 (2008) 227-239
9. Hamblin M.R., and Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem Photobiol Sci 3 (2004) 436-450
10. Maisch T. A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment. Mini Rev Med Chem 9 (2009) 947-983
11. Tang H.M., Hamblin M.R., and Yow C.M. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother 13 (2007) 87-91
12. Lauro F.M., Pretto P., Covolo L., Jori G., and Bertoloni G. Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem Photobiol Sci 1 (2002) 468-470
13. Moan J., and Peng Q. An outline of the hundred-year history of PDT. Anticancer Res 23 (2003) 3591-3600
14. Nitzan Y., Gutterman M., Malik Z., and Ehrenberg B. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 55 (1992) 89-96
15. Minnock A., Vernon D.I., Schofield J., Griffiths J., Parish J.H., and Brown S.B. Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob Agents Chemother 44 (2000) 522-527
16. Bertoloni G., Rossi F., Valduga G., Jori G., and van Lier J. Photosensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia coli. FEMS Microbiol Lett 59 (1990) 149-155
17. Lazzeri D., Rovera M., Pascual L., and Durantini E.N. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem Photobiol 80 (2004) 286-293
18. Segalla A., Borsarelli C.D., Braslavsky S.E., et al. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem Photobiol Sci 1 (2002) 641-648
19. Minnock A., Vernon D.I., Schofield J., Griffiths J., Parish J.H., and Brown S.T. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol B 32 (1996) 159-164
20. Usacheva M.N., Teichert M.C., and Biel M.A. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med 29 (2001) 165-173
21. Wainwright M., and Crossley K.B. Methylene Blue-a therapeutic dye for all seasons?. J Chemother 14 (2002) 431-443
22. Wainwright M., Phoenix D.A., Laycock S.L., Wareing D.R., and Wright P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 160 (1998) 177-181
23. Maisch T., Bosl C., Szeimies R.M., Lehn N., and Abels C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother 49 (2005) 1542-1552
24. Kussovski V., Mantareva V., Angelov I., et al. Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity. FEMS Microbiol Lett 294 (2009) 133-140
25. Tegos G.P., Demidova T.N., Arcila-Lopez D., et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 12 (2005) 1127-1135
26. Hamblin M.R., O'Donnell D.A., Murthy N., et al. Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother 49 (2002) 941-951
27. Soukos N.S., Ximenez-Fyvie L.A., Hamblin M.R., Socransky S.S., and Hasan T. Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother 42 (1998) 2595-2601
28. Tegos G.P., Anbe M., Yang C., et al. Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother 50 (2006) 1402-1410
29. George S., Hamblin M.R., and Kishen A. Uptake pathways of anionic and cationic photosensitizers into bacteria. Photochem Photobiol Sci 8 (2009) 788-795
30. Demidova T.N., and Hamblin M.R. Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 17 (2004) 245-254
31. Nitzan Y., Balzam-Sudakevitz A., and Ashkenazi H. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J Photochem Photobiol B 42 (1998) 211-218
32. Wilson M., and Pratten J. Lethal photosensitisation of Staphylococcus aureus in vitro: effect of growth phase, serum, and pre-irradiation time. Lasers Surg Med 16 (1995) 272-276
33. Lambrechts S.A., Aalders M.C., Verbraak F.D., Lagerberg J.W., Dankert J.B., and Schuitmaker J.J. Effect of albumin on the photodynamic inactivation of microorganisms by a cationic porphyrin. J Photochem Photobiol B 79 (2005) 51-57
34. Street C.N., Pedigo L., Gibbs A., and Loebel N.G. Antimicrobial photodynamic therapy for the decolonization of methicillin-resistant Staphylococcus aureus from the anterior nares. Proc SPIE 7380 (2009) 10.1117/1112.828279
35. Mohr H., Bachmann B., Klein-Struckmeier A., and Lambrecht B. Virus inactivation of blood products by phenothiazine dyes and light. Photochem Photobiol 65 (1997) 441-445
36. Mohr H., Knuver-Hopf J., Gravemann U., Redecker-Klein A., and Muller T.H. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion 44 (2004) 886-890
37. Mohr H., and Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang 84 (2003) 96-104
38. Ben-Hur E., Geacintov N.E., Studamire B., Kenney M.E., and Horowitz B. The effect of irradiance on virus sterilization and photodynamic damage in red blood cells sensitized by phthalocyanines. Photochem Photobiol 61 (1995) 190-195
39. Ben-Hur E., Barshtein G., Chen S., and Yedgar S. Photodynamic treatment of red blood cell concentrates for virus inactivation enhances red blood cell aggregation: protection with antioxidants. Photochem Photobiol 66 (1997) 509-512
40. Maisch T., Bosl C., Szeimies R.M., Love B., and Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 6 (2007) 545-551
41. Smijs T.G., Bouwstra J.A., Schuitmaker H.J., Talebi M., and Pavel S. A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases. J Antimicrob Chemother 59 (2007) 433-440
42. Rocas I.N., Siqueira Jr. J.F., and Santos K.R. Association of Enterococcus faecalis with different forms of periradicular diseases. J Endod 30 (2004) 315-320
43. Millson C.E., Wilson M., MacRobert A.J., and Bown S.G. Ex vivo treatment of gastric Helicobacter infection by photodynamic therapy. J Photochem Photobiol B 32 (1996) 59-65
44. Wood T.K. Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling. Environ Microbiol 11 (2009) 1-15
45. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322 (2008) 107-131
46. Jain A., Gupta Y., Agrawal R., Khare P., and Jain S.K. Biofilms-a microbial life perspective: a critical review. Crit Rev Ther Drug Carrier Syst 24 (2007) 393-443
47. Demidova T.N., Gad F., Zahra T., Francis K.P., and Hamblin M.R. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B 81 (2005) 15-25
48. Rocchetta H.L., Boylan C.J., Foley J.W., et al. Validation of a noninvasive, real-time imaging technology using bioluminescent escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother 45 (2001) 129-137
49. Francis K.P., Joh D., Bellinger-Kawahara C., Hawkinson M.J., Purchio T.F., and Contag P.R. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68 (2000) 3594-3600
50. Francis K.P., Yu J., Bellinger-Kawahara C., et al. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 69 (2001) 3350-3358
51. Hamblin M.R., O'Donnell D.A., Murthy N., Contag C.H., and Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 75 (2002) 51-57
52. Hamblin M.R., Zahra T., Contag C.H., McManus A.T., and Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 187 (2003) 1717-1725
53. Wong T.W., Wang Y.Y., Sheu H.M., and Chuang Y.C. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother 49 (2005) 895-902
54. Zolfaghari P.S., Packer S., Singer M., et al. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol 9 (2009) 27
55. Orenstein A., Klein D., Kopolovic J., et al. The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol 19 (1997) 307-314
56. Lambrechts S.A., Demidova T.N., Aalders M.C., Hasan T., and Hamblin M.R. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci 4 (2005) 503-509
57. Dai T., Tegos G.P., Lu Z., et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009)
58. Berthiaume F., Reiken S.R., Toner M., Tompkins R.G., and Yarmush M.L. Antibody-targeted photolysis of bacteria in vivo. Biotechnology (NY) 12 (1994) 703-706
59. Gad F., Zahra T., Francis K.P., Hasan T., and Hamblin M.R. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci 3 (2004) 451-458
60. Shibli J.A., Martins M.C., Nociti Jr. F.H., Garcia V.G., and Marcantonio Jr. E. Treatment of ligature-induced peri-implantitis by lethal photosensitization and guided bone regeneration: a preliminary histologic study in dogs. J Periodontol 74 (2003) 338-345
61. Komerik N., Nakanishi H., MacRobert A.J., Henderson B., Speight P., and Wilson M. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob Agents Chemother 47 (2003) 932-940
62. Fernandes L.A., de Almeida J.M., Theodoro L.H., et al. Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats. J Clin Periodontol 36 (2009) 219-228
63. de Almeida J.M., Theodoro L.H., Bosco A.F., Nagata M.J., Bonfante S., and Garcia V.G. Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. J Periodontol 79 (2008) 2156-2165
64. de Almeida J.M., Theodoro L.H., Bosco A.F., Nagata M.J., Oshiiwa M., and Garcia V.G. Influence of photodynamic therapy on the development of ligature-induced periodontitis in rats. J Periodontol 78 (2007) 566-575
65. Sigusch B.W., Pfitzner A., Albrecht V., and Glockmann E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol 76 (2005) 1100-1105
66. Teichert M.C., Jones J.W., Usacheva M.N., and Biel M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 155-160
67. Lin J., Bi L.J., Zhang Z.G., Fu Y.M., and Dong T.T. Toluidine blue-mediated photodynamic therapy of oral wound infections in rats. Lasers Med Sci (2009)
68. Akilov O.E., Kosaka S., O'Riordan K., and Hasan T. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochem Photobiol Sci 6 (2007) 1067-1075
69. Akilov O.E., Kosaka S., O'Riordan K., and Hasan T. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol 16 (2007) 651-660
70. Akilov O.E., Yousaf W., Lukjan S.X., Verma S., and Hasan T. Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Lasers Surg Med 41 (2009) 358-365
71. O'Riordan K., Akilov O.E., Chang S.K., Foley J.W., and Hasan T. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. Photochem Photobiol Sci 6 (2007) 1117-1123
72. Jung J.Y., Seung Kwon P., Chul Ahn J., Ge R., Suh M.W., and Rhee C.K. In vitro and in vivo photodynamic therapy of otitis media in gerbils. Laryngoscope (2009)
73. Bisland S.K., Chien C., Wilson B.C., and Burch S. Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem Photobiol Sci 5 (2006) 31-38
74. Smetana Z., Malik Z., Orenstein A., Mendelson E., and Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med 21 (1997) 351-358
75. Moore C., Wallis C., Melnick J.L., and Kuns M.D. Photodynamic treatment of herpes keratitis. Infect Immun 5 (1972) 169-171
76. Lombard G.F., Tealdi S., and Lanotte M.M. The treatment of neurosurgical infections by lasers and porphyrins. In: Jori G., and Perria C.A. (Eds). Photodynamic therapy of tumors and other diseases (1985), Edizione Libreria Progetto, Padova, Italy 363-366
77. Tolstykh P.I., Stranadko E.F., Koraboev U.M., et al. Experimental study of photodynamic effect on bacterial wound microflora. Zh Mikrobiol Epidemiol Immunobiol (2001) 85-87
78. Stranadko E.F., Koraboev U.M., and Tolstykh M.P. Photodynamic therapy in suppurative diseases of soft tissue. Khirurgiia (Mosk) (2000) 67-70
79. Brown S.B. Clinical developments in antimicrobial PDT. 12th international photodynamic association world congress. Seattle (2009)
80. Gold M.H. Acne and PDT: new techniques with lasers and light sources. Lasers Med Sci 22 (2007) 67-72
81. Houk L.D., and Humphreys T. Masers to magic bullets: an updated history of lasers in dermatology. Clin Dermatol 25 (2007) 434-442
82. Johnsson A., Kjeldstad B., and Melo T.B. Fluorescence from pilosebaceous follicles. Arch Dermatol Res 279 (1987) 190-193
83. Meffert H., Gaunitz K., Gutewort T., and Amlong U.J. Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp. Dermatol Monatsschr 176 (1990) 597-603
84. Ashkenazi H., Malik Z., Harth Y., and Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 35 (2003) 17-24
85. Ramstad S., Le Anh-Vu N., and Johnsson A. The temperature dependence of porphyrin production in Propionibacterium acnes after incubation with 5-aminolevulinic acid (ALA) and its methyl ester (m-ALA). Photochem Photobiol Sci 5 (2006) 66-72
86. Charakida A., Seaton E.D., Charakida M., Mouser P., Avgerinos A., and Chu A.C. Phototherapy in the treatment of acne vulgaris: what is its role?. Am J Clin Dermatol 5 (2004) 211-216
87. Hongcharu W., Taylor C.R., Chang Y., Aghassi D., Suthamjariya K., and Anderson R.R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115 (2000) 183-192
88. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 154 (2006) 969-976
89. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 54 (2006) 647-651
90. Tuchin V.V., Genina E.A., Bashkatov A.N., Simonenko G.V., Odoevskaya O.D., and Altshuler G.B. A pilot study of ICG laser therapy of acne vulgaris: photodynamic and photothermolysis treatment. Lasers Surg Med 33 (2003) 296-310
91. Ryou J.H., Lee S.J., Park Y.M., Kim H.O., and Kim H.S. Acne-photodynamic therapy with intra-lesional injection of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed 25 (2009) 57-58
92. Hong S.B., and Lee M.H. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed 21 (2005) 322-325
93. Gold M.H. Photodynamic therapy with lasers and intense pulsed light. Facial Plast Surg Clin North Am 15 (2007) 145-160
94. Nestor M.S. The use of photodynamic therapy for treatment of acne vulgaris. Dermatol Clin 25 (2007) 47-57
95. Taylor M.N., and Gonzalez M.L. The practicalities of photodynamic therapy in acne vulgaris. Br J Dermatol 160 (2009) 1140-1148
96. Bryld L.E., and Jemec G.B. The bacterial flora of the skin surface following routine MAL-PDT. J Dermatolog Treat 17 (2006) 222-223
97. Ceilley R.I. Advances in the topical treatment of acne and rosacea. J Drugs Dermatol 3 (2004) S12-22
98. Darras-Vercambre S., Carpentier O., Vincent P., Bonnevalle A., and Thomas P. Photodynamic action of red light for treatment of erythrasma: preliminary results. Photodermatol Photoimmunol Photomed 22 (2006) 153-156
99. Yung A., Stables G.I., Fernandez C., Williams J., Bojar R.A., and Goulden V. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp Dermatol 32 (2007) 716-721
100. Calzavara-Pinton P.G., Venturini M., and Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B 78 (2005) 1-6
101. Donnelly R.F., McCarron P.A., and Tunney M.M. Antifungal photodynamic therapy. Microbiol Res 163 (2008) 1-12
102. Donnelly R.F., McCarron P.A., Tunney M.M., and David Woolfson A. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B (2006)
103. Calzavara-Pinton P.G., Venturini M., Capezzera R., Sala R., and Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed 20 (2004) 144-147
104. Kim Y.J., and Kim Y.C. Successful treatment of pityriasis versicolor with 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 143 (2007) 1218-1220
105. Sotiriou E., Koussidou T., Patsatsi A., Apalla Z., and Ioannides D. 5-Aminolevulinic acid-photodynamic treatment for dermatophytic tinea pedis of interdigital type: a small clinical study. J Eur Acad Dermatol Venereol (2008)
106. Moravvej H., Dehghan-Mangabadi M., Abbasian M.R., and Meshkat-Razavi G. Association of rosacea with demodicosis. Arch Iran Med 10 (2007) 199-203
107. Skrlin J., Richter B., Basta-Juzbasic A., et al. Demodicosis and rosacea. Lancet 337 (1991) 734
108. Yamasaki K., Di Nardo A., Bardan A., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13 (2007) 975-980
109. Bryld L.E., and Jemec G.B. Photodynamic therapy in a series of rosacea patients. J Eur Acad Dermatol Venereol 21 (2007) 1199-1202
110. Katz B., and Patel V. Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea. J Drugs Dermatol 5 (2006) 6-8
111. Derkay C.S., and Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 118 (2008) 1236-1247
112. Shikowitz M.J., Abramson A.L., Freeman K., Steinberg B.M., and Nouri M. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 108 (1998) 962-967
113. Abramson A.L., Shikowitz M.J., Mullooly V.M., Steinberg B.M., Amella C.A., and Rothstein H.R. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg 118 (1992) 25-29
114. Bujia J., Feyh J., and Kastenbauer E. Photodynamic therapy with derivatives from hemotoporphyrines for recurrent laryngeal papillomatosis of the children. Early results. Otorrinolaringol Ibero Am 20 (1993) 251-259
115. Ichimura H., Yamaguchi S., Kojima A., et al. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol 8 (2003) 322-325
116. Abdel-Hady E.S., Martin-Hirsch P., Duggan-Keen M., et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 61 (2001) 192-196
117. Ross E.V., Romero R., Kollias N., Crum C., and Anderson R.R. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 137 (1997) 736-742
118. Fehr M.K., Chapman C.F., Krasieva T., et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol 174 (1996) 951-957
119. 2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol 156 (2007) 516-520
120. Szeimies R.M., Schleyer V., Moll I., Stocker M., Landthaler M., and Karrer S. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study. Dermatol Surg 35 (2009) 757-764
121. Herzinger T., Wienecke R., Weisenseel P., Borelli C., Berking C., and Degitz K. Photodynamic therapy of genital condylomata in men. Clin Exp Dermatol 31 (2006) 51-53
122. Wang X.L., Wang H.W., Wang H.S., Xu S.Z., Liao K.H., and Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol 151 (2004) 880-885
123. Schroeter C.A., Pleunis J., van Nispen tot Pannerden C., Reineke T., and Neumann H.A. Photodynamic therapy: new treatment for therapy-resistant plantar warts. Dermatol Surg 31 (2005) 71-75
124. Stender I.M., Lock-Andersen J., and Wulf H.C. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 24 (1999) 154-159
125. Stender I.M., Na R., Fogh H., Gluud C., and Wulf H.C. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 355 (2000) 963-966
126. Stender I.M., Borgbjerg F.M., Villumsen J., Lock-Andersen J., and Wulf H.C. Pain induced by photodynamic therapy of warts. Photodermatol Photoimmunol Photomed 22 (2006) 304-309
127. Gold M.H., Boring M.M., Bridges T.M., and Bradshaw V.L. The successful use of ALA-PDT in the treatment of recalcitrant molluscum contagiosum. J Drugs Dermatol 3 (2004) 187-190
128. Scheinfeld N. Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapelene. Dermatol Online J 13 (2007) 15
129. Roome A.P., Tinkler A.E., Hilton A.L., Montefiore D.G., and Waller D. Neutral red with photoinactivation in the treatment of herpes genitalis. Br J Vener Dis 51 (1975) 130-133
130. Kaufman R.H., Gardner H.L., Brown D., Wallis C., Rawls W.E., and Melnick J.L. Herpes genitalis treated by photodynamic inactivation of virus. Am J Obstet Gynecol 117 (1973) 1144-1146
131. Bockstahler L.E., Lytle C.D., and Hellman K.B. A review of photodynamic therapy for herpes simplex: benefits and potential risks. N Y J Dent 45 (1975) 148-157
132. Myers M.G., Oxman M.N., Clark J.E., and Arndt K.A. Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections. N Engl J Med 293 (1975) 945-949
133. Friedrich Jr. E.G., Kaufman R.H., Lynch P.J., and Woodruff D. Vulvar histology after neutral red photoinactivation of herpes simplex virus. Obstet Gynecol 48 (1976) 564-570
134. Asilian A., and Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol (2006)
135. Gardlo K., Horska Z., Enk C.D., et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 48 (2003) 893-896
136. Sohl S., Kauer F., Paasch U., and Simon J.C. Photodynamic treatment of cutaneous leishmaniasis. J Dtsch Dermatol Ges 5 (2007) 128-130
137. Gonzalez U., Pinart M., Reveiz L., and Alvar J. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev (2008) CD005067
138. de Oliveira R.R., Schwartz-Filho H.O., Novaes A.B., et al. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: cytokine profile in gingival crevicular fluid, preliminary results. J Periodontol 80 (2009) 98-105
139. Chondros P., Nikolidakis D., Christodoulides N., Rossler R., Gutknecht N., and Sculean A. Photodynamic therapy as adjunct to non-surgical periodontal treatment in patients on periodontal maintenance: a randomized controlled clinical trial. Lasers Med Sci (2008)
140. Braun A., Dehn C., Krause F., and Jepsen S. Short-term clinical effects of adjunctive antimicrobial photodynamic therapy in periodontal treatment: a randomized clinical trial. J Clin Periodontol 35 (2008) 877-884
141. Christodoulides N., Nikolidakis D., Chondros P., et al. Photodynamic therapy as an adjunct to non-surgical periodontal treatment: a randomized, controlled clinical trial. J Periodontol 79 (2008) 1638-1644
142. Qin Y.L., Luan X.L., Bi L.J., Sheng Y.Q., Zhou C.N., and Zhang Z.G. Comparison of toluidine blue-mediated photodynamic therapy and conventional scaling treatment for periodontitis in rats. J Periodontal Res 43 (2008) 162-167
143. Garcez A.S., Nunez S.C., Hamblin M.R., and Ribeiro M.S. Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod 34 (2008) 138-142
144. Pinheiro S.L., Schenka A.A., Neto A.A., de Souza C.P., Rodriguez H.M., and Ribeiro M.C. Photodynamic therapy in endodontic treatment of deciduous teeth. Lasers Med Sci (2008)
145. Savarino V., Zentilin P., Pivari M., et al. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther 14 (2000) 893-900
146. Jodlowski T.Z., Lam S., and Ashby Jr. C.R. Emerging therapies for the treatment of Helicobacter pylori infections. Ann Pharmacother 42 (2008) 1621-1639
147. Wilder-Smith C.H., Wilder-Smith P., Grosjean P., et al. Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg Med 31 (2002) 18-22
148. Hamblin M.R., Viveiros J., Yang C., Ahmadi A., Ganz R.A., and Tolkoff M.J. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 49 (2005) 2822-2827
149. Ganz R.A., Viveiros J., Ahmad A., et al. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 36 (2005) 260-265
150. Lembo A.J., Ganz R.A., Sheth S., et al. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med 41 (2009) 337-344
151. Castano A.P., Mroz P., and Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6 (2006) 535-545
152. Komerik N., Wilson M., and Poole S. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol 72 (2000) 676-680